Ocular Therapeutix, Inc. (OCUL)
9.05
-0.11
(-1.20%)
USD |
NASDAQ |
Feb 12, 16:00
9.05
0.00 (0.00%)
After-Hours: 17:02
Ocular Therapeutix EPS Diluted (Quarterly) : -0.29 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Bristol Myers Squibb Co. | 0.5326 |
| Krystal Biotech, Inc. | 2.660 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -64.65M |
| Revenue (Quarterly) | 13.25M |
| Total Expenses (Quarterly) | 77.90M |
| Enterprise Value | 1.334B |
| Gross Profit Margin (Quarterly) | 87.97% |
| Profit Margin (Quarterly) | -488.0% |
| Earnings Yield | -15.89% |
| Normalized Earnings Yield | -15.78 |